Shu-Hui Liu is the Chief Scientific Officer at Multitude Therapeutics, bringing over 20 years of experience as a tumor biologist in the biopharmaceutical industry. She specializes in developing large molecule therapeutics for oncology, including ADCs and CAR T cells, and holds a Ph. D. from National Tsing Hua University.
While personal hobbies are private, she demonstrates a clear passion for scientific advancement and community engagement. She actively participates in industry conferences as a speaker and publicly celebrates the successes and collaborations of other teams within the biopharma space.
She is a listed inventor on multiple patents for novel antibody-based cancer therapies developed during her tenure at Pfizer.
Read the full overview →Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.
Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.
Discover additional public profiles from our index.
Looking for someone else? Search here for anyone.